Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)

Authors: Tarek I. Hassanein, Robin C. Hilsabeck, William Perry

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

A primary obstacle to early diagnosis and treatment of hepatic encephalopathy (HE) is the lack of a well-validated, standardized assessment method. The purpose of this study was to present preliminary validity data on a new method of grading HE, the Hepatic Encephalopathy Scoring Algorithm (HESA), which combines clinical impressions with neuropsychological performances to characterize HE. Participants were 49 inpatients admitted for complications of end stage liver disease. Each participant’s level of HE was graded using HESA and the West Haven Criteria (WHC) by independent raters blinded to each other’s rating. A moderately strong association was found between the two grading methods (r = 0.60), and individual HESA clinical and neuropsychological indicators were good discriminators among grades. The results also suggest HESA may be more sensitive to mental status impairment in the middle grades of HE than WHC. These findings suggest HESA holds promise as a multi-method approach to grading all levels of HE.
Literature
1.
go back to reference Groeneweg M, Quero JC, De Bruijn I, Hartmann IJC, Essink-Bot M, Hop WCJ, Schalm SW (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49PubMedCrossRef Groeneweg M, Quero JC, De Bruijn I, Hartmann IJC, Essink-Bot M, Hop WCJ, Schalm SW (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49PubMedCrossRef
2.
go back to reference Bustamante J, Rimola A, Ventura PJ, Navasa M, Ciera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895PubMedCrossRef Bustamante J, Rimola A, Ventura PJ, Navasa M, Ciera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895PubMedCrossRef
3.
go back to reference Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT and the Members of the Working Party (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology. Hepatology 35:716–721 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT and the Members of the Working Party (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology. Hepatology 35:716–721
4.
go back to reference Montagnese S, Amodio P, Morgan MY (2004) Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis 19:281–312PubMedCrossRef Montagnese S, Amodio P, Morgan MY (2004) Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis 19:281–312PubMedCrossRef
5.
go back to reference Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573–583PubMed Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573–583PubMed
6.
go back to reference Atterbury CE, Maddrey WC, Conn HO (1978) Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trail. Am J Dig Dis 23:398–406PubMedCrossRef Atterbury CE, Maddrey WC, Conn HO (1978) Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trail. Am J Dig Dis 23:398–406PubMedCrossRef
7.
go back to reference Huda A, Guze BH, Thomas MA, Bugbee M, Fairbanks L, Strouse T, Fawzy FI (1998) Clinical correlation of neuropsychological test with H magnetic resonance spectroscopy in hepatic encephalopathy. Psychosom Med 60:550–556PubMed Huda A, Guze BH, Thomas MA, Bugbee M, Fairbanks L, Strouse T, Fawzy FI (1998) Clinical correlation of neuropsychological test with H magnetic resonance spectroscopy in hepatic encephalopathy. Psychosom Med 60:550–556PubMed
8.
go back to reference Quero Guillen JC, Soria IC, Garcia Montes JM, Jimenez Saenz M, Herrarias Gutierrez JM (2003) Hepatic encephalopathy: nomenclature, pathogenesis, and treatment. Rev Esp Enferm Dig 95:135–142PubMed Quero Guillen JC, Soria IC, Garcia Montes JM, Jimenez Saenz M, Herrarias Gutierrez JM (2003) Hepatic encephalopathy: nomenclature, pathogenesis, and treatment. Rev Esp Enferm Dig 95:135–142PubMed
9.
go back to reference Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253–267PubMedCrossRef Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253–267PubMedCrossRef
10.
go back to reference Blei AT (1996) Hepatic encephalopathy. In: Kaplowitz N (ed) Liver and biliary diseases, 2nd edn. Williams & Wilkins, Baltimore, pp 615–628 Blei AT (1996) Hepatic encephalopathy. In: Kaplowitz N (ed) Liver and biliary diseases, 2nd edn. Williams & Wilkins, Baltimore, pp 615–628
11.
go back to reference Wechsler D (1987) Wechsler Memory Scale – Revised: manual. The Psychological Corp, San Antonio Wechsler D (1987) Wechsler Memory Scale – Revised: manual. The Psychological Corp, San Antonio
12.
go back to reference Brandt J (1991) The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 5:125–142CrossRef Brandt J (1991) The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 5:125–142CrossRef
13.
go back to reference Benedict RHB (1997) Brief Visuospatial Memory Test – Revised: manual. The Psychological Corp, San Antonio Benedict RHB (1997) Brief Visuospatial Memory Test – Revised: manual. The Psychological Corp, San Antonio
14.
go back to reference Tryon WW, Orr DA, Blumenfield M (1996) Psychometric equivalency of an electronic visual-analog (EVA), a conventional visual-analog, and a Likert rating scale. Int J Method Psychiatric Res 6:123–127CrossRef Tryon WW, Orr DA, Blumenfield M (1996) Psychometric equivalency of an electronic visual-analog (EVA), a conventional visual-analog, and a Likert rating scale. Int J Method Psychiatric Res 6:123–127CrossRef
15.
go back to reference Maurer TJ, Pierce HR (1998) A comparison of Likert scale and traditional measures of self-efficacy. J Appl Psychol 83:324–329CrossRef Maurer TJ, Pierce HR (1998) A comparison of Likert scale and traditional measures of self-efficacy. J Appl Psychol 83:324–329CrossRef
16.
go back to reference Jensen MP, Turner JA, Romano JM, Fisher LD (1999) Comparative reliability and validity of chronic pain intensity measures. Pain 83:157–162PubMedCrossRef Jensen MP, Turner JA, Romano JM, Fisher LD (1999) Comparative reliability and validity of chronic pain intensity measures. Pain 83:157–162PubMedCrossRef
17.
go back to reference Wilkinson GS (1993) Wide Range Achievement Test – 3rd revision: manual. The Psychological Corp, San Antonio Wilkinson GS (1993) Wide Range Achievement Test – 3rd revision: manual. The Psychological Corp, San Antonio
18.
go back to reference Wechsler D (1997) Wechsler Adult Intelligence Scale – 3rd edition: manual. The Psychological Corp, San Antonio Wechsler D (1997) Wechsler Adult Intelligence Scale – 3rd edition: manual. The Psychological Corp, San Antonio
19.
go back to reference Randolph C (1998) Repeatable battery for the assessment of neuropsychological status: manual. The Psychological Corp, San Antonio Randolph C (1998) Repeatable battery for the assessment of neuropsychological status: manual. The Psychological Corp, San Antonio
20.
go back to reference Gilberstadt S, Gilberstadt H, Zieve L, Buegel B, Collier R, McClain C (1980) Psychomotor performance deficits in cirrhotic patients without overt encephalopathy. Arch Int Med 140:519–521CrossRef Gilberstadt S, Gilberstadt H, Zieve L, Buegel B, Collier R, McClain C (1980) Psychomotor performance deficits in cirrhotic patients without overt encephalopathy. Arch Int Med 140:519–521CrossRef
21.
go back to reference McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C (1996) Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 53:758–763PubMed McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C (1996) Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 53:758–763PubMed
22.
go back to reference Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRef Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRef
23.
go back to reference Hassanein T, Tofteng F, Brown RS, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology (in press) Hassanein T, Tofteng F, Brown RS, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology (in press)
Metadata
Title
Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)
Authors
Tarek I. Hassanein
Robin C. Hilsabeck
William Perry
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9895-0

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.